Yuao Wu gives an oral presentation at ACIS2021, The 10th Australian Colloid and Surface Science Symposium, Brisbane, 8-9 February 2021. He presents his findings on the development of cerium oxide-iron oxide hybrid nanoparticles for theranostics of ROS-related and inflammatory diseases. The nanoparticles are effective MRI contrast agents and have excellent ROS quenching and anti-inflammation effects demonstrated in both in vitro and in vivo studies.
